ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 641233 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 641233; 2) Community: the network communities that were significantly associated with the response to NSC 641233; 3) Molecule: the relationships between components within communities and NSC 641233; 4) MDR: the compounds that were significantly associated with the NSC 641233.

NSC Compound Enrichment Correlation
NSC 744020 methyl 1-(4-[(11aR)-7-methoxy-5-oxo-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-8-yl]oxybutyl)-2-(1-methyl-1H-3-indolyl)-1H-benzo[d]imidazole-6-carboxylate 0.0462077035966084 0.2030069
NSC 759322 MEVASTATIN 0.0462077035966084 -0.080147331
NSC 84167 Null 0.0462077035966084 0.31349928
NSC 112758 Rubomycin 0.0462077035966088 0.29897128
NSC 134725 K-33 0.0462077035966088 0.18697612
NSC 268993 Deferoxamine hydrochloride 0.0462077035966088 0.15873985
NSC 57199 3-[o-[Bis(.beta.-chloroethyl)amino]phenyl]-DL-alanine 0.0467178916101838 0.11957224
NSC 647638 1,2-Dioxin-3-acetic acid, 3,6-dihydro-6-methoxy-6-(14,16- octadecadienyl)-, methyl ester, [3.alpha.,6.alpha.,6(14E,16E)]-(+)- (9CI) 0.046717891610184 -0.22137973
NSC 649150 Null 0.046717891610184 0.37269782
NSC 655105 Cycloshikonin 0.046717891610184 0.23965758
Total:102  Current:97    [First] [Prev] [Next] [Last]